APA (7th ed.) Citation

Laloi, L., Billotey, N. C., Dumas, P., Paul, F., Villate, A., Simand, C., . . . Kaphan, E. (2023). Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy. Cancer Medicine, 12(6), 7175. https://doi.org/10.1002/cam4.5459

Chicago Style (17th ed.) Citation

Laloi, Louise, et al. "Retrospective, Real‐life Study of Venetoclax Plus Azacitidine or Low‐dose Cytarabine in French Patients with Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy." Cancer Medicine 12, no. 6 (2023): 7175. https://doi.org/10.1002/cam4.5459.

MLA (9th ed.) Citation

Laloi, Louise, et al. "Retrospective, Real‐life Study of Venetoclax Plus Azacitidine or Low‐dose Cytarabine in French Patients with Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy." Cancer Medicine, vol. 12, no. 6, 2023, p. 7175, https://doi.org/10.1002/cam4.5459.